METTL3-silenced CSCs inhibit GSC maintenance and enhance radiation sensitivity by stabilizing the downstream target SOX2 with recruitment of the HuR, suggesting that METTL3 functions as an oncogene in GBM (Visvanathan et al. 2018). This evidence concerns the gene METTL3 and glioblastoma.